Published in Infect Immun on May 01, 1993
Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media. J Bacteriol (1993) 2.44
Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest (1997) 1.76
HbiF regulates type 1 fimbriation independently of FimB and FimE. Infect Immun (2006) 1.11
Why Serological Responses during Cystitis are Limited. Pathogens (2016) 0.75
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun (1985) 2.82
Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans. J Infect Dis (1978) 2.40
Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili. Infect Immun (1982) 2.39
Mannose-binding activity of Escherichia coli: a determinant of attachment and ingestion of the bacteria by macrophages. Infect Immun (1980) 1.98
Virulence factors of the bacterial cell surface. J Infect Dis (1978) 1.95
The bacteriology of intra-abdominal infections. Surg Clin North Am (1975) 1.70
Impaired colonization by and full invasiveness of Escherichia coli K1 bearing a site-directed mutation in the type 1 pilin gene. Infect Immun (1990) 1.57
The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann Surg (1991) 1.47
Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron (1990) 1.41
Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog (1986) 1.40
Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun (1985) 1.35
Expression of Escherichia coli F-18 type 1 fimbriae in the streptomycin-treated mouse large intestine. Infect Immun (1991) 1.24
Bacterial virulence in urinary tract infection. Infect Dis Clin North Am (1987) 1.23
Principles and limitations of operative management of intraabdominal infections. World J Surg (1990) 1.23
Bacteria, toxins, and the peritoneum. World J Surg (1990) 1.18
Bacterial virulence and pathogenesis: an overview. Rev Infect Dis (1983) 1.17
Surgical infection stratification system for intra-abdominal infection. Multicenter trial. Arch Surg (1985) 1.14
Neutrophil killing of two type 1 fimbria-bearing Escherichia coli strains: dependence on respiratory burst activation. Infect Immun (1990) 1.10
Effect of type 1 piliation on in vitro killing of Escherichia coli by mouse peritoneal macrophages. Infect Immun (1990) 1.07
Change in degree of type 1 piliation of Escherichia coli during experimental peritonitis in the mouse. Infect Immun (1986) 1.04
The role of type 1 pili in the pathogenesis of Escherichia coli infections: a short review and some new ideas. Microb Pathog (1990) 0.88
The open abdomen. The Marlex mesh and zipper technique: a method of managing intraperitoneal infection. Surg Clin North Am (1988) 0.86
Generalized peritonitis. To irrigate or not to irrigate the abdominal cavity. Arch Surg (1982) 0.82
Human neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively augmented by recombinant human tumor necrosis factor-alpha. J Infect Dis (1991) 0.79
The complete genome sequence of Escherichia coli K-12. Science (1997) 84.27
"Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A (1998) 5.02
A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med (1992) 3.95
Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med (2001) 2.41
Persistent occult hypoperfusion is associated with a significant increase in infection rate and mortality in major trauma patients. J Trauma (2000) 2.09
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation (1996) 2.09
Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology (1996) 2.07
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. Am Surg (1999) 1.61
The evolution and direction of OPTN oversight of live organ donation and transplantation in the United States. Am J Transplant (2008) 1.61
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology (2000) 1.50
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA (1999) 1.49
The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann Surg (1991) 1.47
Puberty decreases insulin sensitivity. J Pediatr (1987) 1.45
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity. Am J Transplant (2009) 1.44
Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41
Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches. Liver Transpl (2000) 1.39
The "July phenomenon" and the care of the severely injured patient: fact or fiction? Surgery (2001) 1.34
Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab (1995) 1.33
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res (1994) 1.32
Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg (1997) 1.31
Type-specific contributions to chromosome size differences in Escherichia coli. Infect Immun (1999) 1.29
New tools for integrated genetic and physical analyses of the Escherichia coli chromosome. Gene (1995) 1.29
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis (2009) 1.29
Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24
Mammalian bites. Compr Ther (1983) 1.15
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
A descriptive analysis of students seeking HIV antibody testing at a university health service. J Am Coll Health (1999) 1.14
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol (2007) 1.11
Perceived health needs of inner-city street prostitutes: a preliminary study. Am J Health Behav (2001) 1.11
Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes. Ann Surg (1986) 1.10
Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun (1985) 1.08
Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation (2001) 1.07
Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg (1999) 1.06
Paraquat-mediated selection for mutations in the manganese-superoxide dismutase gene sodA. J Bacteriol (1986) 1.05
Transmission of uropathogens between sex partners. J Infect Dis (1997) 1.05
Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology (1998) 1.05
Fever patterns. Their lack of clinical significance. Arch Intern Med (1979) 1.04
Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Am J Kidney Dis (2000) 1.04
Wound infections. Surg Clin North Am (1994) 1.04
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02
New ultrarare restriction site-carrying transposons for bacterial genomics. Gene (1997) 1.02
Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant (2006) 1.00
Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. Am J Transplant (2007) 0.99
Gastropleural fistula. Report of three cases and review of the literature. Am J Surg (1985) 0.98
Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis. Arch Surg (1985) 0.98
Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened? Arch Surg (1999) 0.98
Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells. J Biol Chem (1983) 0.98
Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity. Liver Transpl (2000) 0.96
Comparison of APACHE II scoring in liver and kidney transplant recipients versus trauma and general surgical patients in a single intensive-care unit. Clin Transplant (1995) 0.96
Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant (1995) 0.95
Proposed thresholds for pancreatic tissue volume for safe intraportal islet autotransplantation after total pancreatectomy. Am J Transplant (2013) 0.94
Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun (2001) 0.93
Accuracy and significance of pretransplant liver volume measured by magnetic resonance imaging. Liver Transpl Surg (1996) 0.93
Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant (1999) 0.92
Diagnosis of intra-abdominal infection in the critically ill patient. Curr Opin Crit Care (2001) 0.92
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol Cell Physiol (2013) 0.92
Percutaneous aspiration and drainage for suspected abdominal infection. Surgery (1984) 0.92
Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg (1992) 0.92
Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant (2000) 0.92
Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis. Infect Immun (2000) 0.92
Cecal volvulus: a different twist for the serious runner. N Engl J Med (1985) 0.91
Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am Surg (1992) 0.91
Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg (1994) 0.91
Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect (Larchmt) (2001) 0.90
Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential. Am J Transplant (2013) 0.90
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group. Transplantation (1996) 0.89
The role of type 1 pili in the pathogenesis of Escherichia coli infections: a short review and some new ideas. Microb Pathog (1990) 0.88
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg (1998) 0.88
Determination of conjugated bile acids in human bile and duodenal fluid by reverse-phase high-performance liquid chromatography. J Lipid Res (1978) 0.88
Bacteremia associated with central venous catheter infection is not an independent predictor of outcomes. J Am Coll Surg (2000) 0.88
Integrated genomic map from uropathogenic Escherichia coli J96. Infect Immun (2000) 0.88
Surgical infection and the aging population. Am Surg (2001) 0.87
Glucose metabolism after pancreas autotransplantation. The effect of open duct versus urinary bladder drainage technique. Ann Surg (1991) 0.87
Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation. Transplantation (1996) 0.86